4.8 Article

Large-scale discovery of novel genetic causes of developmental disorders

Journal

NATURE
Volume 519, Issue 7542, Pages 223-+

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/nature14135

Keywords

-

Funding

  1. Chief Scientist Office of the Scottish Government Health Directorates [CZD/16/6]
  2. Scottish Funding Council [HR03006]
  3. Health Innovation Challenge Fund [HICF-1009-003]
  4. Wellcome Trust
  5. Department of Health
  6. Wellcome Trust Sanger Institute [WT098051]
  7. National Institute for Health Research, through the Comprehensive Clinical Research Network
  8. Cambridge South REC [10/H0305/83]
  9. Republic of Ireland REC [GEN/284/12]
  10. Cancer Research UK [15934] Funding Source: researchfish
  11. Medical Research Council [MC_PC_U127561093] Funding Source: researchfish
  12. National Institute for Health Research [NF-SI-0510-10282] Funding Source: researchfish
  13. MRC [MC_PC_U127561093] Funding Source: UKRI

Ask authors/readers for more resources

Despite three decades of successful, predominantly phenotype-driven discovery of the genetic causes of monogenic disorders(1), up to half of children with severe developmental disorders of probable genetic origin remain without a genetic diagnosis. Particularly challenging are those disorders rare enough to have eluded recognition as a discrete clinical entity, those with highly variable clinical manifestations, and those that are difficult to distinguish from other, very similar, disorders. Here we demonstrate the power of using an unbiased genotype-driven approach(2) to identify subsets of patients with similar disorders. By studying 1,133 children with severe, undiagnosed developmental disorders, and their parents, using a combination of exome sequencing(3-11) and array-based detection of chromosomal rearrangements, we discovered 12 novel genes associated with developmental disorders. These newly implicated genes increase by 10% (from 28% to 31%) the proportion of children that could be diagnosed. Clustering of missense mutations in six of these newly implicated genes suggests that normal development is being perturbed by an activating or dominant-negative mechanism. Our findings demonstrate the value of adopting a comprehensive strategy, both genome-wide and nationwide, to elucidate the underlying causes of rare genetic disorders.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available